Company intelligence / Profile preview

Bio&Bio

Daejeon, Daejeon, South Korea

Ownership: Private
Development stage: Other

Overview

Bio&Bio is a South Korean biotechnology company specializing in the development and manufacture of advanced molecular diagnostic solutions. The company focuses on real-time PCR-based kits for the detection of various infectious diseases, including respiratory viruses and foodborne pathogens. Bio&Bio provides integrated diagnostic systems and reagents to clinical laboratories and healthcare providers globally. Their product portfolio includes nucleic acid extraction kits and automated diagnostic platforms designed for high-throughput testing. The company gained significant prominence during the COVID-19 pandemic for its rapid development and supply of PCR detection kits.

Therapeutic areas: Infectious Diseases
Modalities: Molecular diagnosticsPCR
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Bio&Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio&Bio.

Explore the full profile